Naba Alsaha Medical Services Co.

Naba Alsaha Medical Services Co.

TTADAWUL:9546
23.30
SAR
+0.80
(+3.56%)
462.00MMarket Cap
Naba Alsaha Medical Services Co.
TADAWUL:9546
(Saudi Exchange)

Recent

price

23.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
TTM
SAR
5.6
6.18
8.68
9.25
9.61
- -
Revenue per Share
1.23
1.28
2.49
1.04
1.31
- -
Basic EPS, GAAP
0.97
1.16
-0.58
-0.15
-2.44
- -
Free Cash Flow per Basic Share
- -
0.1
0.1
- -
0.15
- -
Dividend per Share
4.9
6.19
8.58
9.51
10.61
11.34
Book Value per Share
4.79
6.04
8.42
9.35
10.44
11.15
Tangible Book Value per Share
21
21
21
21
21
21
Basic Weighted Avg Shares
118
130
182
194
202
- -
Sales/Revenue/Turnover
23.7
21.83
23.56
12.62
15.26
- -
Operating Margin (%)
6
7
9
11
12
- -
Depreciation Expense
26
27
52
22
28
- -
Net Income, GAAP
6.18
6.95
4.52
13.06
10.15
- -
Effective Tax Rate (%)
21.95
20.76
28.73
11.21
13.64
- -
Profit Margin (%)
49
58
81
125
117
139
Working Capital
23
12
38
87
121
160
LT Debt
103
130
180
200
223
238
Total Equity
- -
17.9
21.28
8.18
8.68
- -
Return on Invested Capital (%)
- -
18.9
27.86
8.7
8.94
- -
Return on Capital (%)
- -
23.12
33.78
11.47
13.03
- -
Return on Common Equity (%)

Capital Structure

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
2
2
1
LT Borrowings
84
121
160
LT Finance Leases
2
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21
21
21
Market Capitalization
704
515
462

Working Capital

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
119
139
165
Cash, Cash Equivalents & STI
7
19
32
Accounts Receivable, Net
96
105
116
Inventories
10
8
11
Total Current Liabilities
26
22
26
Payables & Accruals
- -
- -
- -
ST Debt
2
2
1
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
11.62%
Free Cash Flow
- -
- -
1,511.99%
Net Income, GAAP
- -
- -
26.37%
Sales/Revenue/Turnover
- -
- -
3.88%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
194
2025
- -
- -
202
2026
- -
- -
- -

Semi-annual Earnings Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1.04
2025
- -
- -
1.31
2026
- -
- -
- -

Semi-annual Dividends Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
0.15
2026
- -
- -
- -
Business
Naba Alsaha Medical Services Company SCJSC (9546.SR) operates and manages private and governmental hospitals, health facilities, and related medical services in the Kingdom of Saudi Arabia. The company owns and manages Al-Zahraa Hospital, offering outpatient clinics, inpatient hospitalization, surgical operations, emergency and intensive care services, laboratory testing, and an integrated radiology center; Manarat Al-Haramain Pharmacy, providing pharmaceutical services to outpatients; Naba Alsaha Branch for maintenance works, building operations, and cleaning services; and Naba Alsaha Branch for architectural contracting, including construction and maintenance of medical facilities. It also provides strategic consulting, training for medical and administrative personnel, development of therapeutic programs, quality management, and pharmacy operations. Founded in 1984 and headquartered in Qatif, Eastern Province, the company primarily serves the Saudi healthcare market, with all revenue generated domestically. In recent developments, Naba Alsaha completed the merger with its subsidiary Al Anwar Medical Company, approved by shareholders in March 2024 and effective December 28, 2024, with no change to its capital structure. The company aims to double its bed capacity from 180 in 2023 to 400 beds over three years through projects including the Riyadh Hospital and expansion of Al-Anwar Hospital in Hail. In October 2025, it mutually terminated a 25-year lease contract with the Hail Region Municipality for a hospital site and awarded contracts worth SAR 3.7 million for medical equipment supply and installation, alongside other contracts totaling SAR 12 million.